Farming Industry - Bayer will have to pay a considerably lower amount in the glyphosate lawsuit.
"Even though the court has lowered the illegally inflated compensation amount, we disagree with their verdict on this issue," the corporation stated on a Wednesday. The hearing was marked by major blunders that required rectification.
Bayer also underlined the fact that the business had won 14 out of the last 20 trials it faced. Many of the accusations had been resolved, it emphasized.
The difficulties regarding the herbicide Roundup, which contains glyphosate, were discovered by Bayer in 2018 during its takeover of the American company Monsanto. That same year, the first lawsuit against the German company was decided. This caused a flood of lawsuits in the United States. In 2020, Bayer introduced a billion-dollar plan to settle most of the claims without attributing any liability. A considerable number of cases have been dealt with, but potential risks still exist. As of the end of January, approximately 54,000 of the estimated 165,000 unresolved cases remained active. Bayer has spent €13 billion on the Roundup litigation so far. The provisions were set at $6.3 billion ($5.7 billion) at the end of 2023.
Read also:
- Despite the reduction in the compensation amount in the glyphosate lawsuit in Philadelphia, Bayer, based in Leverkusen, Germany, expressed disagreement with the verdict.
- In a legal dispute stemming from the use of Roundup, which contains glyphosate, Bayer faced multiple lawsuits in the USA following its acquisition of the American company Monsanto in 2018.
- In a bid to resolve most of the legal issues surrounding its pharmaceutical product, Bayer launched a billion-dollar settlement plan in 2020, with operations in both the USA and Germany.
- In a significant development, Bayer announced that it had dealt with a substantial number of glyphosate-related lawsuits, but the threat of potential risks still loomed large, with approximately 54,000 cases remaining active as of January 202X.
- The glyphosate lawsuit and subsequent settlement have resulted in significant financial implications for Bayer, with the company having spent €13 billion on Roundup litigation to date, with provisions of $6.3 billion set by the end of 2023.